Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacology and Therapeutics | journal | 4.450 Q1 | 233 | 131 | 331 | 24955 | 4010 | 330 | 11.62 | 190.50 | |
2 | Drug Resistance Updates | journal | 3.794 Q1 | 132 | 31 | 41 | 5374 | 454 | 41 | 12.10 | 173.35 | |
3 | Perspectives in Medicinal Chemistry | journal | 2.425 Q1 | 17 | 2 | 8 | 277 | 83 | 8 | 10.38 | 138.50 | |
4 | Drug Metabolism Reviews | journal | 1.129 Q1 | 108 | 33 | 98 | 4523 | 401 | 94 | 4.15 | 137.06 | |
5 | Current Neuropharmacology | journal | 1.385 Q1 | 103 | 120 | 169 | 12931 | 723 | 150 | 3.15 | 107.76 | |
6 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 11 | 76 | 1147 | 143 | 63 | 1.25 | 104.27 | ||
7 | Drug Safety - Case Reports | journal | 0.241 Q3 | 3 | 1 | 2 | 102 | 2 | 2 | 1.00 | 102.00 | |
8 | Neurotherapeutics | journal | 2.283 Q1 | 136 | 80 | 225 | 7887 | 1273 | 211 | 5.65 | 98.59 | |
9 | Current Psychopharmacology | journal | 0.109 Q4 | 4 | 16 | 4 | 1576 | 1 | 3 | 0.25 | 98.50 | |
10 | Vaccines | journal | 1.457 Q1 | 85 | 48 | 95 | 4565 | 385 | 92 | 4.08 | 95.10 | |
11 | Expert Opinion on Emerging Drugs | journal | 0.762 Q2 | 54 | 38 | 131 | 3609 | 377 | 127 | 3.21 | 94.97 | |
12 | Current Topics in Pharmacology | journal | 0.126 Q4 | 8 | 4 | 37 | 377 | 6 | 37 | 0.19 | 94.25 | |
13 | Journal of Cardiovascular Development and Disease | journal | 32 | 33 | 37 | 3037 | 48 | 35 | 1.30 | 92.03 | ||
14 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.041 Q2 | 52 | 34 | 73 | 3074 | 256 | 69 | 3.29 | 90.41 | |
15 | Methods in Pharmacology and Toxicology | book series | 0.129 Q4 | 14 | 119 | 133 | 10654 | 42 | 120 | 0.32 | 89.53 | |
16 | Expert Opinion on Investigational Drugs | journal | 1.210 Q1 | 117 | 126 | 411 | 11124 | 1545 | 405 | 3.80 | 88.29 | |
17 | CNS Drugs | journal | 1.819 Q1 | 129 | 89 | 269 | 7703 | 1484 | 257 | 5.12 | 86.55 | |
18 | Expert Review of Neurotherapeutics | journal | 1.102 Q1 | 98 | 141 | 411 | 11575 | 1262 | 388 | 3.15 | 82.09 | |
19 | Cochrane Database of Systematic Reviews | journal | 2.197 Q1 | 327 | 1435 | 5067 | 112923 | 23234 | 5016 | 4.21 | 78.69 | |
20 | PharmaNutrition | journal | 0.613 Q2 | 30 | 18 | 72 | 1392 | 149 | 67 | 1.72 | 77.33 | |
21 | Expert Opinion on Orphan Drugs | journal | 0.268 Q3 | 27 | 129 | 354 | 9882 | 205 | 350 | 0.56 | 76.60 | |
22 | Expert Opinion on Pharmacotherapy | journal | 1.014 Q2 | 93 | 238 | 734 | 17781 | 2325 | 715 | 3.40 | 74.71 | |
23 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 15 | 69 | 1119 | 78 | 65 | 0.96 | 74.60 | ||
24 | Chinese Herbal Medicines | journal | 18 | 1 | 0 | 73 | 0 | 0 | 0.00 | 73.00 | ||
25 | Expert Opinion on Drug Safety | journal | 1.297 Q1 | 90 | 181 | 410 | 12923 | 1446 | 401 | 3.74 | 71.40 | |
26 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 35 | 134 | 2490 | 247 | 122 | 1.59 | 71.14 | ||
27 | Expert Review of Clinical Pharmacology | journal | 1.040 Q2 | 60 | 156 | 228 | 11087 | 661 | 208 | 2.84 | 71.07 | |
28 | PPAR Research | journal | 1.079 Q2 | 59 | 31 | 88 | 2200 | 248 | 85 | 2.87 | 70.97 | |
29 | Antibiotics | journal | 0.714 Q2 | 77 | 37 | 111 | 2457 | 234 | 108 | 2.08 | 66.41 | |
30 | Experimental and Clinical Psychopharmacology | journal | 1.275 Q1 | 101 | 47 | 170 | 3081 | 431 | 167 | 2.45 | 65.55 | |
31 | Expert Review of Anticancer Therapy | journal | 0.760 Q2 | 85 | 144 | 443 | 9425 | 861 | 423 | 2.08 | 65.45 | |
32 | Frontiers in Pharmacology | journal | 1.729 Q1 | 154 | 515 | 725 | 33384 | 3101 | 671 | 4.37 | 64.82 | |
33 | Drugs | journal | 1.588 Q1 | 188 | 149 | 467 | 9620 | 2541 | 461 | 5.50 | 64.56 | |
34 | Current Treatment Options in Oncology | journal | 1.208 Q1 | 66 | 65 | 160 | 4113 | 507 | 160 | 3.38 | 63.28 | |
35 | BioDrugs | journal | 1.035 Q2 | 79 | 48 | 139 | 2995 | 476 | 131 | 3.18 | 62.40 | |
36 | Journal of Biomedical Science | journal | 1.221 Q1 | 110 | 88 | 298 | 5452 | 947 | 298 | 3.09 | 61.95 | |
37 | Journal of Psychopharmacology | journal | 2.095 Q1 | 135 | 140 | 391 | 8640 | 1810 | 372 | 4.69 | 61.71 | |
38 | Clinical Pharmacokinetics | journal | 1.599 Q1 | 184 | 110 | 269 | 6748 | 1381 | 244 | 4.68 | 61.35 | |
39 | Side Effects of Drugs Annual | book series | 0.114 Q4 | 9 | 49 | 157 | 2983 | 11 | 0 | 0.07 | 60.88 | |
40 | Current Cardiovascular Risk Reports | journal | 0.475 Q3 | 34 | 44 | 190 | 2606 | 172 | 190 | 0.92 | 59.23 | |
41 | Drugs and Aging | journal | 1.263 Q1 | 109 | 88 | 280 | 5141 | 1023 | 273 | 3.23 | 58.42 | |
42 | Biologics: Targets and Therapy | journal | 1.133 Q1 | 47 | 18 | 65 | 1047 | 276 | 63 | 3.76 | 58.17 | |
43 | Therapeutic Advances in Infectious Disease | journal | 1.074 Q2 | 29 | 13 | 26 | 750 | 92 | 23 | 2.67 | 57.69 | |
44 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.836 Q1 | 47 | 39 | 86 | 2201 | 440 | 86 | 5.43 | 56.44 | |
45 | Drug Safety | journal | 1.454 Q1 | 140 | 105 | 313 | 5877 | 1117 | 270 | 3.47 | 55.97 | |
46 | International Journal of Neuropsychopharmacology | journal | 1.997 Q1 | 125 | 118 | 598 | 6544 | 2678 | 587 | 4.38 | 55.46 | |
47 | Paediatric Drugs | journal | 0.986 Q2 | 70 | 44 | 147 | 2433 | 407 | 139 | 2.56 | 55.30 | |
48 | European Neuropsychopharmacology | journal | 2.085 Q1 | 130 | 192 | 622 | 10425 | 2925 | 605 | 4.52 | 54.30 | |
49 | Contemporary Clinical Trials | journal | 1.266 Q1 | 75 | 154 | 488 | 8231 | 1166 | 472 | 2.30 | 53.45 | |
50 | Therapeutic Advances in Respiratory Disease | journal | 0.955 Q2 | 50 | 48 | 82 | 2539 | 230 | 74 | 2.98 | 52.90 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®